Dual Mechanoenzymatic Kinetic Resolution of (±)‐Ketorolac

Mario Pérez‐Venegas, Agustín Mario Rodríguez‐Treviño, Eusebio Juaristi

doi:10.1002/cctc.201902292

<jats:title>Abstract</jats:title><jats:p>Recently, biocatalysis mediated by mechanical energy has become a convenient strategy to obtain highly valuable products following the principles of green chemistry. In particular, mechanoenzymatic techniques have allowed the isolation of chiral drugs with high enantiomeric purity. In this regard, being aware of the preponderant anti‐inflammatory activity of Ketorolac's (<jats:italic>S</jats:italic>)‐isomer relative to its (<jats:italic>R</jats:italic>)‐enantiomer, we developed a mechanoenzymatic kinetic resolution protocol using <jats:italic>Candida antarctica</jats:italic> Lipase B to yield both enantiomers with high enantiopurity. The significant enantiopreference of CALB for the (<jats:italic>R</jats:italic>)‐isomer of Ketorolac allowed the isolation of the active (<jats:italic>S</jats:italic>)‐enantiomer, either by means of an enantioselective esterification of racemic Ketorolac or <jats:italic>via</jats:italic> enantioselective hydrolysis of suitable ester derivatives. Both techniques proceeded in short reaction times, with high enantiomeric excess (>83 %), remarkable enantiodiscrimination (<jats:italic>E</jats:italic>≫500) and rather good conversion (46 %). Furthermore, (<jats:italic>R</jats:italic>)‐Ketorolac, an effective drug for ovarian cancer management, was obtained in essentially enantiopure form (<jats:italic>ee</jats:italic> >99 %).</jats:p>

Dual Mechanoenzymatic Kinetic Resolution of (±)‐Ketorolac

Search this article

Description

Journal

Citations (1)*help

Details 詳細情報について

Export

Report a problem